Healthcare Services

Cancer biopsy market projected to reach $53.38B by 2030 at 13.3% CAGR

April 20, 2026April 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Cancer Biopsy Market Expected To Change From 2026 To 2030?

The cancer biopsy market has experienced rapid expansion in recent years. It is anticipated to increase from $28.52 billion in 2025 to $32.41 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 13.6%. This historical growth can be attributed to a rising global incidence of cancer, the proliferation of diagnostic imaging facilities, the widespread adoption of tissue biopsy as a standard diagnostic method, the expansion of pathology laboratory networks, and technological improvements in biopsy devices.

The cancer biopsy market size is anticipated to undergo significant expansion in the upcoming years, with projections indicating it will reach $53.38 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 13.3%. This growth during the forecast period is fueled by an increasing need for precision oncology diagnostics, the rising adoption of liquid biopsy testing, the expansion of personalized cancer treatment planning, growing investments in molecular diagnostics, and an intensifying focus on early-stage cancer screening. Notable trends expected in this period include the wider acceptance of liquid biopsy techniques, an increase in the application of image-guided biopsy procedures, the growing integration of molecular pathology testing, the proliferation of minimally invasive biopsy devices, and an enhanced emphasis on detecting cancer early.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/cancer-biopsy-global-market-report

What Factors Are Contributing To The Growth Of The Cancer Biopsy Market?

The growing incidence of cancer is anticipated to fuel the expansion of the cancer biopsy market in the coming years. Cancer constitutes an intricate set of illnesses defined by the uncontrolled multiplication and dissemination of cells. This rise in cancer cases stems from various elements, including shifts in lifestyle and urbanization, environmental contamination, consumption of tobacco and alcohol, along with issues concerning healthcare access and public awareness. To diagnose and evaluate the specific type, stage, and extent of cancer, a cancer biopsy involves taking and examining tissue or cells from a suspected region. For example, the World Health Organization, an intergovernmental body based in Switzerland, reported in February 2024 that new cancer cases are projected to exceed 35 million by 2050, indicating a 77% surge from the approximately 20 million cases estimated in 2022. Consequently, the rising occurrence of cancer is a key driver for the cancer biopsy market.

What Are The Main Segments Within The Cancer Biopsy Market Segment Structure?

The cancer biopsy market covered in this report is segmented –

1) By Type: Tissue Biopsies, Liquid Biopsies, Other Types

2) By Application: Breast Cancer, Colorectal Cancer, Cervical Cancers, Lung Cancers, Prostate Cancers, Skin Cancers, Blood Cancers, Kidney Cancers, Other Applications

3) By End User: Hospitals, Diagnostic Laboratories, Other End Users

Subsegments:

1) By Tissue Biopsies: Core Needle Biopsies, Fine Needle Aspiration (FNA) Biopsies, Incisional Biopsies, Excisional Biopsies

2) By Liquid Biopsies: Circulating Tumor Cell (CTC) Analysis, Circulating Tumor DNA (ctDNA) Testing, Plasma Biomarker Testing

3) By Other Types: Bone Biopsies, Endoscopic Biopsies, Brush Biopsies, Skin Biopsies

What Trends Are Shaping The Future Of The Cancer Biopsy Market?

Prominent companies operating within the cancer biopsy market are actively developing liquid biopsy techniques. These advancements aim to facilitate non-invasive, early cancer detection and monitoring, enhance patient outcomes, and enable more personalized treatment strategies. Liquid biopsy represents an advanced, non-invasive diagnostic method that identifies and analyzes genetic material, such as circulating tumor DNA (ctDNA), RNA, exosomes, and other biomarkers, from a blood sample. For example, in May 2023, Labcorp, a US-based company focused on manufacturing cancer biopsies, launched Labcorp Plasma Focus, a plasma-focused liquid biopsy designed to detect cancer-related biomarkers. The Plasma Focus test analyzes circulating cell-free DNA (cfDNA) released from tumor cells into the bloodstream, allowing for the construction of a genomic profile of the patient’s tumor and the identification of mutations across 33 genes associated with various cancers, including non-small cell lung cancer, colorectal cancer, breast cancer, esophageal cancer, and melanoma.

Who Are The Companies Participating In The Cancer Biopsy Market?

Major companies operating in the cancer biopsy market are Thermo Fisher Scientific Inc., Danaher Corporation, Becton Dickinson and Company, Roche Diagnostics GmbH, Hologic Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Exact Sciences Corporation, Myriad Genetics Inc., Guardant Health Inc., Veracyte Inc., GRAIL Inc., Freenome Holdings Inc., Biodesix Inc., Chronix Biomedical Inc., Biocept Inc., Personal Genome Diagnostics Inc., Agena Bioscience Inc., Oncimmune Holdings plc, Exosome Diagnostics Inc., Epigenomics AG, Genesystems Inc., Lucence Diagnostics Pte. Ltd., ANGLE plc

Get The Full Cancer Biopsy Market Report:

https://www.thebusinessresearchcompany.com/report/cancer-biopsy-global-market-report

Which Geographic Region Dominates The Cancer Biopsy Market?

North America was the largest region in the cancer biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Cancer Biopsy Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/cancer-biopsy-global-market-report

Browse Through More Reports Similar to the Global Cancer Biopsy Market 2026, By The Business Research Company

Breast Cancer Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/breast-cancer-drugs-global-market-report

Skin Cancer Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/skin-cancer-drugs-global-market-report

Pancreatic Cancer Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/pancreatic-cancer-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795